about
Sleep-disordered breathing and heart failure a dangerous liaison.Prognostic significance of serial high-sensitivity troponin I measurements following acute cardiac decompensation-correlation with longer-term clinical outcomes and reverse remodelling.The patient with dyspnea. Rational diagnostic evaluation.Reverse epidemiology in different stages of heart failure.Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.Prognostic value of aldosterone and cortisol in patients hospitalized for acutely decompensated chronic heart failure with and without mineralocorticoid receptor antagonism.Frequency and prognostic impact of mid-expiratory flow reduction in stable patients six months after hospitalisation for heart failure with reduced ejection fraction.Dysnatraemia in heart failure.[Cardiac remodeling after myocardial infarction : Clinical practice update].Prevalence of cardiovascular risk factors and diseases in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantationRemodelling and adverse remodelling in CAD[Treatment of chronic left ventricular failure]Airway obstruction in systolic heart failure--COPD or congestion?Airway obstruction in patients with cardiac diseasesThe omega-3 index in patients with heart failure: A prospective cohort study[Diabetic Kidney Disease - How to Protect the Kidney?]CREDENCE and DELIGHT deliver on renal benefits
P50
Q37397985-083B7DA3-C999-4030-AE0F-96A2D6B0F487Q38382297-EA173AD1-B921-4BAF-AD51-C23C5F1E4AEEQ39212072-9C758EB7-4C8F-4C5D-9F9C-8E3E574F0C08Q41358655-0CB50BB6-9590-47D3-989D-0F41F816119BQ47760332-C00B35FC-D514-4B78-8C2C-2616F74397C7Q48047576-ADCE8976-380B-4590-98BF-C301C0E59362Q51064592-4139D1C1-661A-4180-9443-9902DE39D185Q51075620-0B44BAC7-4A8A-47DC-A2D2-01698C082A08Q51341584-8D8E513A-DD11-42A3-8F0E-5AFD668AF4E1Q54559647-D7BB5200-F35D-4E40-BA52-5F9E39CB95B1Q64255987-15750F89-8B73-48DA-BD0D-4D564BDF34B9Q84891083-4C429F9D-E60B-417E-9186-496BDEB2E9A3Q84919701-EC52B3C2-FA84-4764-88C7-5EC98A7BDFB9Q86030572-E053212B-540C-49EF-9EA4-B6C83881B21EQ87302832-A0C1ABD3-9D80-43CA-91EE-18BD696C7233Q90548382-73443F85-17CA-4341-8598-75E360B36C17Q92518276-8E81764F-F542-4D65-885F-868739EEA7EBQ93025266-FDF3B703-7176-4562-976B-4AD8A8B291C9
P50
description
investigador
@es
researcher
@en
name
Susanne Brenner
@en
type
label
Susanne Brenner
@en
prefLabel
Susanne Brenner
@en
P108
P31
P496
0000-0003-3051-9498